Open-Label Treatment of Moderate or Marked Melasma with a 4% Hydroquinone Skin Care System Plus 0.05% Tretinoin Cream

Objective: To evaluate treating epidermal melasma using a 4% hydroquinone skin care system plus tretinoin 0.05% cream. Design: Multicenter open-label study with all patients receiving above-mentioned treatment for up to 24 weeks. Setting: Private dermatology and plastic surgery clinics and clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gold, Michael, Rendon, Marta, Dibernardo, Barry, Bruce, Suzanne, Lucas-Anthony, Chere, Watson, Joanne
Médium: Artigo
Jazyk:Inglês
Vydáno: Matrix Medical Communications 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848650/
https://ncbi.nlm.nih.gov/pubmed/24307923
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky